180 related articles for article (PubMed ID: 11113777)
21. Drugs can reduce the incidence of breast cancer: now what?
Wozniak TF; Eppes PG; Wilson CT
Del Med J; 1999 Sep; 71(9):387-9. PubMed ID: 10584440
[No Abstract] [Full Text] [Related]
22. Prevention of hormone-related cancers: breast cancer.
Dunn BK; Wickerham DL; Ford LG
J Clin Oncol; 2005 Jan; 23(2):357-67. PubMed ID: 15637398
[TBL] [Abstract][Full Text] [Related]
23. Risks and benefits of therapy with menopausal hormones versus selective estrogen-receptor modulators in peri- and postmenopausal women at increased breast cancer risk.
Col NF; Chlebowski RT
Menopause; 2008; 15(4 Suppl):804-9. PubMed ID: 18596602
[TBL] [Abstract][Full Text] [Related]
24. Recent results from clinical trials using SERMs to reduce the risk of breast cancer.
Vogel VG
Ann N Y Acad Sci; 2006 Nov; 1089():127-42. PubMed ID: 17261762
[TBL] [Abstract][Full Text] [Related]
25. Moving forward with breast cancer prevention.
Chen WY; Rosner B; Colditz GA
Cancer; 2007 Jun; 109(12):2387-91. PubMed ID: 17464950
[No Abstract] [Full Text] [Related]
26. SERMs: meeting the promise of multifunctional medicines.
Jordan VC
J Natl Cancer Inst; 2007 Mar; 99(5):350-6. PubMed ID: 17341726
[TBL] [Abstract][Full Text] [Related]
27. Raloxifene use in clinical practice: efficacy and safety.
Goldstein SR; Duvernoy CS; Calaf J; Adachi JD; Mershon JL; Dowsett SA; Agnusdei D; Stuenkel CA
Menopause; 2009; 16(2):413-21. PubMed ID: 19092711
[TBL] [Abstract][Full Text] [Related]
28. How should we inform women at higher risk of breast cancer about tamoxifen? An approach with a decision guide.
McKay A; Martin W; Latosinsky S
Breast Cancer Res Treat; 2005 Nov; 94(2):153-9. PubMed ID: 16261414
[TBL] [Abstract][Full Text] [Related]
29. Optimising endocrine approaches for the chemoprevention of breast cancer beyond the Study of Tamoxifen and Raloxifene (STAR) trial.
Jordan VC
Eur J Cancer; 2006 Nov; 42(17):2909-13. PubMed ID: 17064889
[TBL] [Abstract][Full Text] [Related]
30. Two good choices to prevent breast cancer: great taste, less filling.
Hortobagyi GN; Brown PH
Cancer Prev Res (Phila); 2010 Jun; 3(6):681-5. PubMed ID: 20522797
[TBL] [Abstract][Full Text] [Related]
31. Task force cautious about chemoprevention. Official guidelines are out about taking tamoxifen and raloxifene to prevent breast cancer. These drugs can help, but they aren't for everyone.
Harv Womens Health Watch; 2002 Oct; 10(2):1-2. PubMed ID: 12393316
[No Abstract] [Full Text] [Related]
32. A reconsideration of tamoxifen use for breast cancer.
Wang PH; Chao HT
Taiwan J Obstet Gynecol; 2007 Jun; 46(2):93-5. PubMed ID: 17638615
[No Abstract] [Full Text] [Related]
33. Interest in breast cancer chemoprevention among older women.
Tjia J; Micco E; Armstrong K
Breast Cancer Res Treat; 2008 Apr; 108(3):435-53. PubMed ID: 17554628
[TBL] [Abstract][Full Text] [Related]
34. Raloxifene reduces risk of vertebral fractures [corrected] in postmenopausal women regardless of prior hormone therapy.
Johnell O; Cauley JA; Kulkarni PM; Wong M; Stock JL
J Fam Pract; 2004 Oct; 53(10):789-96. PubMed ID: 15469774
[TBL] [Abstract][Full Text] [Related]
35. Breast carcinoma chemoprevention in the community setting. Estimating risks and benefits.
Brewster AM; Christo DK; Lai H; Helzlsouer K
Cancer; 2005 Mar; 103(6):1147-53. PubMed ID: 15674856
[TBL] [Abstract][Full Text] [Related]
36. Raloxifene for the treatment and prevention of breast cancer?
Pappas SG; Jordan VC
Expert Rev Anticancer Ther; 2001 Oct; 1(3):334-40. PubMed ID: 12113100
[TBL] [Abstract][Full Text] [Related]
37. Prevention of breast cancer in high-risk women.
Kardinal CG; Veith R
J La State Med Soc; 1999 Apr; 151(4):198-201. PubMed ID: 10234895
[TBL] [Abstract][Full Text] [Related]
38. The lack, need, and opportunities for decision-making and informational tools to educate primary-care physicians and women about breast cancer chemoprevention.
Ravdin PM
Cancer Prev Res (Phila); 2010 Jun; 3(6):686-8. PubMed ID: 20522798
[TBL] [Abstract][Full Text] [Related]
39. Preventing breast cancer in high-risk women, 2008.
Vogel VG
Oncology (Williston Park); 2008 May; 22(6):666-73; discussion 679, 682, 684. PubMed ID: 18561555
[TBL] [Abstract][Full Text] [Related]
40. [Breast cancer chemoprevention (tamoxifen, raloxifene, and others)].
Funahashi H
Nihon Rinsho; 2000 Apr; 58 Suppl():587-91. PubMed ID: 11026055
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
